A Study in Healthy Male Volunteers Investigating the Safety, Absorption and Elimination of Single Doses of GLPG4059

NCT04575818 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Development of compound has been stopped

Conditions

Healthy

Interventions

DRUG: GLPG4059 oral suspension
DRUG: Placebo
DRUG: GLPG4059 tablet

Sponsor

Lakefront Biotherapeutics NV